Related Experiment Videos
Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia
S K Myöhänen1, S B Baylin, J G Herman
1The Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Abstract:
Inactivation of p16ink4A and other tumor suppressor genes has been associated with promoter region hypermethylation in neoplasia. However, direct proof for aberrant DNA methylation as an independent event for loss of gene function has been difficult to obtain. We addressed this question in the colon carcinoma cell line HCT116, which contains one allele of p16ink4A with a coding region frameshift mutation and one wild-type allele. Neither allele contains a mutation in the proximal promoter region. The promoter of the wild-type allele, but not the mutant allele, is hypermethylated, and only the mutant allele is expressed. Transcription from the methylated/wild-type allele was restored after cell treatment with the demethylating agent 5-aza-2'-deoxycytidine. Thus, in neoplastic cells, stable allele-specific loss of transcription may arise from aberrant methylation of a nonmutated promoter region, identifying hypermethylation as a direct mechanism for tumor suppressor gene inactivation.
Insights
Aberrant DNA methylation directly inactivates tumor suppressor genes like p16ink4A in cancer. This study demonstrates hypermethylation causes gene silencing, even without mutations, proving it
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Tumor suppressor gene inactivation is crucial in cancer development.
- Promoter hypermethylation is linked to gene silencing in neoplasia.
- Direct evidence linking methylation to gene loss has been limited.
Purpose of the Study:
- To investigate if DNA hypermethylation can independently cause tumor suppressor gene inactivation.
- To demonstrate a direct mechanism for gene silencing in colon carcinoma.
Main Methods:
- Utilized the HCT116 colon carcinoma cell line with one mutant and one wild-type p16ink4A allele.
- Analyzed promoter methylation status of both alleles.
- Assessed gene expression following treatment with a demethylating agent (5-aza-2'-deoxycytidine).
Main Results:
- The wild-type p16ink4A allele promoter was hypermethylated, while the mutant allele's was not.
- Only the mutant allele was expressed, indicating silencing of the wild-type allele.
- Demethylation treatment restored transcription from the previously silenced wild-type allele.
Conclusions:
- Aberrant promoter hypermethylation can directly cause allele-specific gene silencing in neoplastic cells.
- This epigenetic event acts as a mechanism for tumor suppressor gene inactivation, independent of coding mutations.
- Identifies DNA methylation as a direct driver of tumor suppressor loss in cancer.